This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Eastman Chemical (EMN) Q1 Earnings Lag, Sales Beat Estimates
by Zacks Equity Research
Eastman Chemical (EMN) gains on innovation-driven growth model, strong end-market demand and pricing actions amid headwinds from higher raw material costs.
Eastman Chemical (EMN) Q1 Earnings Miss Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of -0.48% and 10.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Eastman Chemical (EMN)
by Zacks Equity Research
Eastman Chemical (EMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Chemical Stock Q1 Earnings Slated on Apr 28: EMN, CE, HUN & OLN
by Anindya Barman
Chemical companies' Q1 results are likely to have been driven by higher demand and the benefits of strategic actions amid headwinds from input cost inflation. Let's see how EMN, CE, HUN and OLN are poised ahead of their earnings releases.
Eastman Chemical (EMN) to Post Q1 Earnings: Factors at Play
by Zacks Equity Research
Eastman Chemical's (EMN) Q1 earnings are likely to have benefited from cost-management actions and revenues from innovation.
Eastman Chemical (EMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? Eastman Chemical (EMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Why Eastman Chemical (EMN) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why You Should Retain Eastman Chemical (EMN) in Your Portfolio
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from higher input costs, it benefits from productivity actions and innovation.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman (EMN) Enters Negotiation for Molecular Recycling Site
by Zacks Equity Research
Eastman Chemical's (EMN) negotiation with Port-Jerome-sur-Seine authorities is a significant step toward an important milestone in the company's plan to invest up to $1 billion.
Eastman Chemical (EMN) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Gains on Cost Actions and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-cutting and productivity actions and efforts to drive new business revenues from innovation.
Univar (UNVR) Inks Deal With Particle Dynamics, Boosts Portfolio
by Zacks Equity Research
Univar (UNVR) will provide United States and Canada customers with Particle Dynamics' compressible calcium and magnesium carbonates and microencapsulated vitamins and minerals.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman (EMN) Provides Kingsport Incident Update & Q1 View
by Zacks Equity Research
Eastman Chemical (EMN) forecasts first-quarter earnings per share in the range of $2.05-$2.25.
Eastman (EMN) Boosts Tertiary Amine Capacity in Ghent & Pace
by Zacks Equity Research
Eastman's (EMN) investments to expand its tertiary amine capacity showcase its strong commitment to its home and personal care customers.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Q4 Earnings Miss, Sales Beat Estimates
by Zacks Equity Research
Eastman Chemical (EMN) benefits from strong growth of its specialty product lines on the back of its innovation-driven growth model in Q4.
Eastman Chemical (EMN) Lags Q4 Earnings Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of -4.23% and 11.10%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Earnings Charts to Key in On
by Tracey Ryniec
These five companies are in industries that will give us a look into where the economy is headed in 2022.
Methanex (MEOH) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Methanex (MEOH) delivered earnings and revenue surprises of -5.08% and 3.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) to Invest $1B in Recycling Facility
by Zacks Equity Research
Eastman Chemical's (EMN) investment is a major step forward in its strategy to accelerate a circular economy globally.